Cargando…

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice

BACKGROUND: Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hongyan, Yang, Jing, Liu, Yun-Qiang, Lei, Song, Yang, Mei, Yang, Zhi, Yang, Yuan, Hu, Zhangxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934380/
https://www.ncbi.nlm.nih.gov/pubmed/33663537
http://dx.doi.org/10.1186/s12967-021-02765-x
_version_ 1783660802534801408
author Wu, Hongyan
Yang, Jing
Liu, Yun-Qiang
Lei, Song
Yang, Mei
Yang, Zhi
Yang, Yuan
Hu, Zhangxue
author_facet Wu, Hongyan
Yang, Jing
Liu, Yun-Qiang
Lei, Song
Yang, Mei
Yang, Zhi
Yang, Yuan
Hu, Zhangxue
author_sort Wu, Hongyan
collection PubMed
description BACKGROUND: Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. METHOD: Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (−/−) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin–creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. RESULTS: After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4–6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 ± 3.1 µg/mL vs.: 22.2 ± 4.5 µg/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 µg/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin–creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (−/−) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. CONCLUSIONS: In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-021-02765-x.
format Online
Article
Text
id pubmed-7934380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79343802021-03-08 Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice Wu, Hongyan Yang, Jing Liu, Yun-Qiang Lei, Song Yang, Mei Yang, Zhi Yang, Yuan Hu, Zhangxue J Transl Med Research BACKGROUND: Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. METHOD: Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (−/−) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin–creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. RESULTS: After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4–6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 ± 3.1 µg/mL vs.: 22.2 ± 4.5 µg/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 µg/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin–creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (−/−) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. CONCLUSIONS: In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-021-02765-x. BioMed Central 2021-03-04 /pmc/articles/PMC7934380/ /pubmed/33663537 http://dx.doi.org/10.1186/s12967-021-02765-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Hongyan
Yang, Jing
Liu, Yun-Qiang
Lei, Song
Yang, Mei
Yang, Zhi
Yang, Yuan
Hu, Zhangxue
Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
title Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
title_full Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
title_fullStr Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
title_full_unstemmed Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
title_short Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
title_sort lipoprotein glomerulopathy induced by apoe kyoto mutation in apoe-deficient mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934380/
https://www.ncbi.nlm.nih.gov/pubmed/33663537
http://dx.doi.org/10.1186/s12967-021-02765-x
work_keys_str_mv AT wuhongyan lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT yangjing lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT liuyunqiang lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT leisong lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT yangmei lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT yangzhi lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT yangyuan lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice
AT huzhangxue lipoproteinglomerulopathyinducedbyapoekyotomutationinapoedeficientmice